The recombinant TbTS protein has both sialidase and trans-sialidase activity, but it is about 10 times more efficient in transferring than in hydro-lysing sialic acid.. brucei trans-sialid
Trang 1The trans -sialidase from the African trypanosome
Trypanosoma brucei
Georgina Montagna1, M Laura Cremona1, Gasto´n Paris1, M Fernanda Amaya2, Alejandro Buschiazzo2, Pedro M Alzari2and Alberto C C Frasch1
1
Instituto de Investigaciones Biotecnolo´gicas – Instituto Tecnolo´gico de Chascomu´s, Consejo Nacional de Investigaciones
Cientı´ficas y Te´cnicas, Universidad Nacional de General San Martı´n, Provincia de Buenos Aires, Argentina;
2
Unite´ de Biochimie Structurale, CNRS URA 2185, Institut Pasteur, Paris, France
Trypanosoma bruceiis the cause of the diseases known as
sleeping sickness in humans (T brucei ssp gambiense and
ssp rhodesiense) and ngana in domestic animals (T brucei
brucei) in Africa Procyclic trypomastigotes, the tsetse vector
stage, express a surface-bound trans-sialidase that transfers
sialic acid to the glycosylphosphatidylinositol anchor of
procyclin, a surface glycoprotein covering the parasite
sur-face Trans-sialidase is a unique enzyme expressed by a few
trypanosomatids that allows them to scavenge sialic acid
from sialylated compounds present in the infected host The
only enzyme extensively characterized is that of the
Ameri-can trypanosome T cruzi (TcTS) In this work we identified
and characterized the gene encoding the trans-sialidase from
T brucei brucei(TbTS) TbTS genes are present at a small
copy number, at variance with American trypanosomes
where a large gene family is present The recombinant TbTS
protein has both sialidase and trans-sialidase activity, but it is about 10 times more efficient in transferring than in hydro-lysing sialic acid Its N-terminus contains a region of 372 amino acids that is 45% identical to the catalytic domain of TcTS and contains the relevant residues required for cata-lysis The enzymatic activity of mutants at key positions involved in the transfer reaction revealed that the catalytic sites of TcTS and TbTS are likely to be similar, but are not identical As in the case of TcTS and TrSA, the substitution
of a conserved tryptophanyl residue changed the substrate specificity rendering a mutant protein capable of hydrolysing both a-(2,3) and a-(2,6)-linked sialoconjugates
Keywords: trans-sialidase; sialidase; T brucei; procyclic trypomastigotes
African trypanosomiasis has re-emerged as a major health
threat, with an epidemic resulting in more than 100 000 new
infections per year With 300 000 cases officially reported,
human trypanosomiasis, or sleeping sickness caused by
Trypanosoma bruceissp gambiense and ssp rhodesiense, has
now returned to the epidemic levels of the 1930s in many
historic foci across Africa T brucei ssp brucei causes the
ngana disease in domestic animals, which can reduce food
production as much as 50% The parasite, which lives and
multiplies in the blood of the infected host, eludes the
immune system by consecutively expressing structurally
different forms of variant surface glycoproteins (VSG) [1]
The VSG coat from the bloodstream form is replaced by the
invariant procyclin surface coat of the procyclic insect stage when entering the tsetse insect vector (Glossina sp.) These procyclins are a small family of very similar acid repetitive proteins [2,3] that might protect procyclic cells from digestion by the digestive enzymes in the fly [4]
Unable to synthesize sialic acids, trypanosomes use a specific enzyme, the trans-sialidase, to scavenge the mono-saccharide from host glycoconjugates and to sialylate acceptor molecules present on the surface of parasite plasma membrane [5] Indeed, the presence of trans-sialidase activity is unique to a few trypanosomes, being absent in all other cell types tested so far Trans-sialidase is a modified sialidase that instead of hydrolysing sialic acid, transfers the monosaccharide to another sugar moiety The only trans-sialidase extensively studied is the one from Trypanosoma cruzi(TcTS) The enzyme is involved in sequestering sialic acid from sialoglycoconjugates present in the blood and other tissues in the infected vertebrate host The sialic acid is transferred to terminal galactoses present in mucins, highly O-glycosylated proteins that cover the parasite surface [5] Sialylated mucins have been suggested to be involved in invasion of the mammalian host cells and in protection against complement lysis [6–8]
In T cruzi and T rangeli (a related American parasite which only displays sialidase activity), trypanosomal sialidases are encoded by a multigenic family [9,10] In
T cruzi, there are about 140 genes, half of them encoding proteins that display enzymatic activity The other mem-bers code for proteins lacking activity due to a mutation
Correspondence to Instituto de Investigaciones Biotecnolo´gicas,
Universidad Nacional de General San Martı´n, INTI,
Avemida Gral Paz s/n, Edificio 24, Casilla de Correo 30,
1650 San Martı´n, Pcia de Buenos Aires, Argentina.
Fax: + 54 11 4752 9639, Tel.: + 54 11 4580 7255,
E-mail: cfrasch@iib.unsam.edu.ar
Abbreviations: TrSA, T rangeli sialidase; TcTS, T cruzi
trans-sialidase; TbTS, T brucei trans-sialidase; VSG,
variant surface glycoproteins; IMAC, iminodiacetic
acid metal affinity chromatography; MUNen5Ac,
2¢-(4-methylum-belliferyl)-a- D -N-acetylneuraminic acid; 3¢SL, sialyl-a-(2,3)-lactose;
6¢SL, sialyl-a-(2,6)-lactose; GSS, Genome Sequence Survey.
(Received 10 January 2002, revised 26 April 2002,
accepted 30 April 2001)
Trang 2Y342H [11] The overall structure of the TcTS comprises
an N-terminal globular region of 642 amino acids carrying
the catalytic activity (see below), followed by a C-terminal
extension of tandemly repeated sequences named SAPA
(shed acute phase antigen) that are not required for the
enzymatic activity SAPA is highly antigenic and is
involved in the stabilization of the enzymatic activity once
released in the blood of the infected host [12] Members in
the sialidase family of T rangeli (TrSA) are about 70%
identical to TcTS [13], and some of them also lack
enzymatic activity
The crystal structures of several microbial sialidases
have been determined They share a similar catalytic
domain that displays a typical six-bladed b propeller
topology originally observed in influenza virus sialidase
[14] Some sialidases are multidomain proteins and include
one or more noncatalytic domains, which may be involved
in carbohydrate recognition, as for the enzymes from
Vibrio cholerae[15] and Micromonospora viridifaciens [16]
The three-dimensional structure of TrSA [17] showed that
trypanosomal enzymes fold into two distinct structural
domains: the b propeller catalytic domain and a tightly
associated C-terminal domain with the characteristic
b barrel topology of plant lectins These crystallographic
studies also showed that they share a similar active site
architecture, where several amino-acid residues critical for
enzyme function, are strictly conserved In T cruzi and
T rangeli, a conserved tryptophan residue (W313) was
recently shown to be implicated in the binding of the
substrate and to be determinant for the specificity for
a-(2,3) linkages [18] Other residues in the surrounding of
the active site differ when the structures of sialidase and
trans-sialidase are compared In particular, two residues
from TcTS, Y119 and P284, were found to be critical for
the transfer reaction and were proposed to modulate the
substrate-binding cleft, providing trans-sialidase with the
capacity for transferring the monosaccharide
We report here the first gene coding for a trans-sialidase
belonging to African trypanosomes The deduced
sialidase protein sequence is only 38% similar to the
trans-sialidase of T cruzi, but conserves all the amino-acid
residues that are relevant for the enzymatic activity Single
point mutation at critical positions, revealed distinct
features between trans-sialidase active sites in American
and African trypanosomes
E X P E R I M E N T A L P R O C E D U R E S
Trypanosomes
Procyclic forms of T brucei brucei stock EATRO427 were
cultivated axenically in SDM-79 as described previously
[19] The strain was kindly provided by F R Opperdoes
(Christian de Duve Institute of Cellular Pathology, Brussels,
Belgium)
Nucleic acid isolation
Total DNA from culture procyclic forms was isolated using
a conventional proteinase K/phenol/chloroform method as
described previously [20] Total RNA was purified using
TRIzol reagent following manufacturer’s instructions (Life
Technologies Inc.)
Southern blot analysis Total DNA was digested with the indicated restriction enzymes and 2.5 lg of the sample per line was electro-phoresed in 0.8% agarose gel and transferred for Southern blot on Zeta-Probe nylon membranes (Bio-Rad) as des-cribed previously [20]
PCR radiolabeling of probes was performed by substi-tuting the nonradioactive dCTP by 30 lCi of [a-32P]dCTP
in a 30-cycle primer extension reaction after optimization of the template and MgCl2 concentration The TbTS probe was made with oligonucleotide FRIP (5¢-ATAAGG TAGAGCGCACTGTGCA-3¢) using clone TbTS digested with EcoRV as template Probe TbTS-like was made from clone pGEM-TbTS-like using oligonucleotide (5¢-CTT GCTAGCCTCTGCAGCCGACAT-3¢) The filters were hybridized with the probes described using hybridization solution containing 0.5M NaH2PO4, 7% SDS, 1 mM
EDTA and 1% BSA, at 62C
Cloning oftrans-sialidase genes PCR was carried out using Vent DNA Polymerase (New England Biolabs) on 100 ng of parasite DNA PCR primers contained restriction enzymes sites to facilitate the subsequent cloning steps in the expression vector For TbTS the primers were as follows: AminoMet (5¢-AT GGAGGAACTCCACCAACAAAT-3¢, forward) and STOP (5¢-TATAGATCTTCAAATCGCCAACACATA CAT-3¢, reverse, underlined is the BglII restriction site) For TbTS-like: TbTSIIamino (5¢-CTTGCTAGCATG CGCGTTGTATACCAG-3¢, forward, underlined is the NheI restriction site) and TbTSIIStop (5¢-AGAGATCT AGAACGCGTGGTCTGC-3¢, reverse, underlined is the BglII restriction site) Primer sequences for TbTS were obtained from Genome Sequence Survey (GSS) AQ661000 for AminoMet and AQ656761 for STOP Primers for TbTS-like were obtained from a BAC clone: AC009463, which contains the complete ORF The PCR products were cloned on pGEM-T Easy vector following the A-tailing procedure The clones were called pGEM-TbTS and pGEM-TbTSlike These clones were used as template for automated (AbiPrism) or manual (dideoxy-chain termination method with Sequenase-USB) sequencing or for subcloning in the expression vector
Cloning of TbTS 5¢ UTR First strand cDNA was prepared with the Superscript II system using an internal primer (5¢-TGAAAATCAACAG CAGTCTC-3¢) that binds to position 58–40 of TbTS ORF RT-PCR was carried out with the primers for T brucei mini-exon as forward (5¢-AACGCTATTATTAGAACA GTTTCTGTACT-3¢) and the one used for first strand synthesis as reverse, using Vent DNA polymerase The product was cloned into pGEM-T Easy vector after A-tailing and sequenced using the dideoxy-chain termin-ation method with Sequenase (USB)
Site-directed mutagenesis Site directed point mutagenesis was performed using the QuikChange Site-directed mutagenesis kit (Stratagene),
Trang 3according to the manufacturer’s instructions All clones
were sequenced to confirm mutation of target sites
Expression oftrans-sialidase genes in bacteria
and protein purification
The plasmid containing the complete ORF of the TbTS
(pGEM-TbTS) was cut with EcoRI and the DNA fragment
corresponding to TbTS gene was ligated into the expression
vector pTrcHisC (Invitrogen) The His-tag encoded in the
plasmid vector was used to purify the recombinant protein
A TbTS construct starting at the codon for leucine 28 was
obtained by PCR on the pGEM-TbTS plasmid using the
followings primers: LTSK (5¢-TATGCTAGCTTGACT
TCCAAGGCTGCGG-3¢, forward, underlined is the NheI
restriction site) and STOP (see above) After digestion with
the corresponding restriction enzymes, the fragment was
ligated to pTrcHisC vector A similar procedure was carried
out for TbTS-like gene, but the PCR reaction was
performed using pGEM-TbTS-like as template and the
followings primers: TbTSIILCS (5¢-CTTGCTAGCCTC
TGCAGCCGACAT-3¢, forward, underlined is the NheI
restriction site) and TbTSIIcarboxi (5¢-TAGAGATCTTA
CATAAATAGGGAATA-3¢, reverse, underlined is the
BglII restriction site) The constructs were introduced in
E coli BL21 (DE3) pLysS cells by the calcium chloride
method Overnight cultures were diluted 1 : 50 in Terrific
Broth and grown at 37C up to D6000.8–1.0, with constant
agitation at 250 r.p.m Bacteria were induced to over
express recombinant protein by adding 0.5 mM isopropyl
thio-b-D-galactoside (Sigma) and induction was maintained
at 18C for 12–16 h Cells were harvested, washed with
NaCl/Tris (20 mMTris/HCl pH 7.6 and 50 mMNaCl) and
frozen ()80 C) until needed After thawing, lysis was
carried out in the presence of 20 mM Tris/HCl pH 7.6,
30 mM NaCl, 0.5% Triton X-100, 1 mM
phenyl-methylsulfonyl fluoride, 100 lgÆmL)1DNAse I
Superna-tants were centrifuged at 21 000 g for 30 min and subjected
to iminodiacetic acid metal affinity chromatography
(IMAC) (HiTrap Chelating, Amersham Pharmacia Biotech
AB) Ni2+-charged equilibrated in 20 mMPipes pH 6.9 and
0.5MNaCl (buffer IMAC) The column was washed with
30 mM imidazole in buffer IMAC Elution was achieved
using a linear gradient 30–250 mM imidazole in buffer
IMAC The activity peak was pooled, dialyzed against
20 mMBistris pH 7.4 and further purified by FPLC anion
exchange (Mono Q) equilibrated with the same buffer The
protein was eluted by applying a linear gradient of
0–250 mMtrisodium citrate Purified proteins were analysed
by SDS/PAGE under reducing conditions, stained with
Coomasie Blue R250, and quantitated with Kodak 1D3.0
software using purified BSA as standard
Enzyme activity assays
Enzyme activity assays were carried out using the purified
proteins as described in the previous section Neuraminidase
activity was determined by measuring the fluorescence of
4-methylumbelliferone released by the hydrolysis of
0.2 mM 2¢-(4-methylumbelliferyl)-a-D-N-acetylneuraminic
acid (MUNen5Ac, Sigma) The assay was performed in
50 lL in 20 mM Pipes pH 6.9 After incubation at 35C,
the reaction was stopped by dilution in 0.2 sodium
carbonate pH 10, and fluorescence was measured with a DYNAQuantTM200 fluorometer (Hoefer Pharmacia Inc) Trans-sialidase activity was measured in 20 mM Pipes
pH 6.9, using 1 mM Neu5Ac-a-(2–3) lactose as sialic acid donor and 12 lM[D-glucose-1-14C]lactose (55 mCiÆmmol)1) (Amersham) as acceptor, in 30 lL final volume at 35C The reaction was stopped by dilution, and sialyl-[14C]lactose was quantitated with a b-scintillation counter as described previously [21] Suitable modifications were made to the standard reaction to obtain the kinetic constants MUNen5Ac is an unspecific substrate and it does not allow
a distinction between hydrolysis of a-(2,3)- and a-(2,6)-linked sialic acid Therefore, in order to determine the substrate specificity of wild-type and mutant proteins, sialidase activity was measured using sialyl-a-(2,3)-lactose (3¢SL) or sialyl-a-(2,6)-lactose (6¢SL) as substrates Quanti-tation of 3¢SL and 6¢SL hydrolysis was carried out by the thiobarbituric method [22] Predefined quantities of wild-type or mutant proteins were incubated with 0.5 mM of either 3¢SL or 6¢SL and 50 mM Hepes pH 7.0, in a final volume of 20 lL for 30 min at 35C The enzymatic reactions were stopped by adding 15 lL of 25 mMNaIO4 solution prepared in 125 mM sulfuric acid solution The mixtures were vortexed and allowed to react in a water bath
at 37C for 30 min Samples were then neutralized with
13 lL of sodium arsenite 2% w/v in HCl (0.5 N) by slow addition of the reactive Tubes were gently vortexed to complete the reduction reaction After the total disappear-ance of yellow colour (5 min) 152 lL of thiobarbituric acid (36 mM, pH 9.0) were added and then incubated in a boiling water bath for 15 min Samples were then cooled in an ice-water bath for 5 min, followed by room-temperature colour stabilization The samples were centrifuged, and 20 lL were separated by high-performance liquid chromatography through a C18reverse phase column (Pharmacia Biotech) using 2 : 3 : 5 water/methanol/buffer (buffer: 0.2% phos-phoric acid; 0.23M sodium perchlorate) Absorbance was measured at 549 nm A sialic acid calibration curve was previously set, and absorbance values were always read in the linear range
R E S U L T S
TheT brucei trans-sialidase primary sequence conserves most of the structurally relevant amino-acid residues of bacterial and protozoan sialidases
corres-ponding to the catalytic domain of TcTS (L26499, a member of family I of T cruzi trans-sialidase/sialidase superfamily [23]) on the T brucei Genome Project Database (Sanger Centre) The search identified six GSSs with aBLAST
Evalue between 2.6· 10)36 and 0.73 When assembled, these fragments built up an open reading frame of 2316 bp Because various sialidase amino-acid motifs such as FRIP and Asp box motifs were conserved in the deduced sequence, this open reading frame might code for a T brucei sialidase-related protein These data were used to design oligonucleotides for the amplification by PCR on genomic DNA to clone the gene coding for the complete TbTS Eleven genes from independent PCRs were sequenced and organized into eight different groups according to their nucleotide sequence (Fig 1) The differences among genes
Trang 4seem not to be randomly distributed, but rather, localized at
nine positions Combinations of mutations at these nine
positions generated eight genes having from one to five
differences Five out of the nine differences are in the first
and second codon positions, giving rise to a high proportion
of nonconservative mutations Most of the differences
(seven out of nine) are located in the catalytic domain (see
below), but they are placed at positions irrelevant for the
enzymatic activity because the corresponding recombinant
proteins displayed both sialidase and trans-sialidase activity
(see next section) The deduced primary structure of the
protein coded by these genes showed that TbTS is organized
into three putative regions (Fig 2) An N-terminal region of
100 amino acids, which is absent in TcTS, a middle region of
372 amino acids, which is 45% identical to the catalytic domain of the T cruzi enzyme and a C-terminal region of
298 amino acids followed by an hydrophobic region likely
to correspond to a GPI-anchor signal TbTS is probably anchored by GPI to the surface membrane since native procyclic trans-sialidase can be released from the parasite by treatment with phospholipase D [24] The 298 amino acids
in the C-terminal domain are 30% identical to the TcTS lectin-like domain TbTS does not have a repetitive domain
at the C-terminus that is homologous to the T cruzi SAPA domain
The catalytic region revealed the conservation of most of the structurally relevant residues displayed in bacterial and protozoan sialidases and trans-sialidases (Fig 2), such as an arginine triad that binds to the carboxylate group common
to all the sialic acid derivatives (R133, R346, R431), a glutamic acid (E473) that stabilizes one of the arginine side chains, a negatively charged group (D157) proposed as a possible proton donor in the hydrolytic reaction and two essential residues at the bottom of the site (E331, Y457), which are well positioned to stabilize a putative sialosyl cation intermediate [25] This tyrosine residue was found to
be a determinant for the catalytic activity of TcTS [11] The comparison of the crystal structure of TrSA with the homologous model of TcTS reveals a few amino acid changes close to the substrate-binding cleft that might modulate the sialyltransferase activity [17] Most of these critical substitutions observed at the periphery of the cleft in TcTS are conserved in the deduced primary sequence of TbTS, including an aromatic residue (Y120 in TcTS) that was found to have a crucial role in the transfer reaction [17] TbTS also conserves an exposed aromatic side chain (W400) that favours, in the case of microbial sialidases and trans-sialidases, the high specificity for sialyl-a-(2,3) substrates [18] The TbTS genes present partially conserved the subterminal VTVxNVfLYNR motif (VIVRNVLLYHR
in T brucei) that in the case of T cruzi, defines the trypanosome trans-sialidase/sialidase superfamily of surface proteins [26] It has been recently shown that this sequence is involved in host cell binding during T cruzi infection process [27]
Expression and properties ofT brucei recombinant trans-sialidase
The entire ORF starting at the codon for the first methionine was identified by sequencing the 5¢ UTR of TbTS mRNA A construct expressed from the codon for this first methionine produced a protein of approximately 84.4 kDa that lacked sialidase and trans-sialidase activities (data not shown) An analysis of the putative start of the mature protein N-terminus using the IPSORT program (Human Genome Center, Institute of Medical Sciences, University of Tokio), predicted the existence of a signal peptide that ends just before leucine 28 The insert was then designed to have this amino acid at position +1 The new construct, which includes an N-terminal extension of 10 amino acids expressing a His-tag, codes for a 745 amino-acid protein with a predicted molecular mass of 81.4 kDa and displaying both sialidase and trans-sialidase activity (data not shown) All further work was performed with this protein To perform kinetic studies, the protein was purified
Fig 2 Comparison of protein structure and sequence between TbTS and
TcTS (A) Primary structure of TbTS and TcTS The positions of the
FRIP, Asp boxes and TcTS superfamily motifs are underlined.
(B) Amino-acid sequence of the conserved region of the catalytic
do-main of TbTS and TcTS The FRIP and the Asp boxes are underlined.
The identity in amino acids between the two primary sequences are
indicated with vertical bars and the boxes highlight the residues involved
in the catalytic centre of the sialidases of known crystal structure.
Fig 1 Differences among TbTS clones Eleven clones of TbTS were
sequenced and analysed They could be classified in eight distinct
groups with differences in only nine positions The nucleotide changes
in the triplet sequence are indicated (uppercase) The mutations that
cause amino-acid changes are boxed.
Trang 5through passage on a iminodiacetic acid metal affinity
column followed by FPLC anionic exchange (see
Experi-mental procedures for details) After the anionic exchange
column, the protein was > 95% pure (Fig 3) MUNen5Ac
was used as substrate to assay for sialidase activity, and a
mix of Neu5Ac-a-(2,3) and Neu5Ac-a-(2,6)-lactose as sialic
acid donor and lactose as acceptor for the trans-sialidase
activity (Fig 3) The affinity for sialyl-lactose as substrate of TbTS (2.27 mM) and TcTS (4.3 mM) were similar, as it was the turnover of both enzymes (apparent Vmax for sialyl-lactose is 51 161 nmolÆmin)1Æmg)1 for TbTS and
32 692 nmolÆmin)1Æmg)1) for TcTS (Fig 3; [18]) As in the case of T cruzi trans-sialidase [18], TbTS behaves as a very efficient sialyl-transferase: in excess of both the donor and acceptor substrates, the enzyme is 11.1 times more efficient
in transferring than hydrolysing donor sialic acid, as can be concluded by comparing the Vmax of the hydrolysis and transference activities (Fig 3) We have also measured the trans-sialidase-sialidase activity ratio in the native T brucei brucei enzyme from procyclic forms, as described under Experimental procedures This ratio was 8.9 Thus, there is a good agreement between values obtained with the recom-binant and native enzymes
Point mutations at critical amino-acid residues revealed features of the catalytic site of African trypanosomestrans-sialidase
Based on the crystal structure of TrSA [17], mutants of TbTS at key positions involved in substrate binding and specificity were constructed and characterized These mutants include (see Fig 4A) the exposed aromatic side chain that favours the sialyl-a-(2,3) substrate specificity (W400 in TbTS mature protein), a tyrosine residue sugges-ted to be part of a second carbohydrate-binding site in the catalytic cleft (Y191 in TbTS), a proline residue that was found to increase the sialidase activity in TrSA (P371 in TbTS) and a tyrosine residue that is well positioned to stabilize a putative sialosyl cation intermediate (Y430 in TbTS) [17]
The mutant proteins were produced and purified with the same criteria described for the wild-type in the previous section As shown in Fig 4B, mutations at positions 371 and 430 of TbTS completely abolished both sialidase and
II
I
-1 min.mg) x 10
1/S (mM -1 )
5.0 4.0 3.0 2.0 1.0
0 5 10 15 20 25
Km: 1.2mM Vmax: 4582 nmol min -1 mg -1
2.5 2.0 1.5 1.0 0.5
0 2.0 4.0 6.0
-1 min.mg)
1/S (mM -1 )
Km: 2.27 mM Vmax: 51161 nmol min -1 mg -1
7 8
Elution (mL)
250
0
kDa
66 97.4
45
9 10 11 Fractions
Fractions
Fig 3 Purification of recombinant TbTS
pro-tein (A) TbTS protein was purified by
anion-exchange chromatography (Mono Q) after
IMAC chelating column The elution profile
of Mono Q is shown Fractions were collected
and analysed by SDS/PAGE as indicated in
Experimental procedures (B) Lineweaver–
Burk plots of sialidase and trans-sialidase
activities I, the sialidase activity was measured
varying the concentrations of MUNen5Ac as
sialic acid donor (see Experimental
proce-dures) II, the trans-sialidase activity was
measured using sialyl-a-(2,3)-lactose and
lac-tose as the sialic acid donor and acceptor
substrates, respectively The apparent
stants were obtained using lactose fixed
con-centration of 2 m M and varying the
concentration of the sialyl lactose according to
the experiment Data are the mean of three
independent experiments.
Catalytic domain Lectin-like
domain
TcTS
TbTS
372
Y
461
TbTS wild type 8074.33 ± 691.52 (100) 100 933.8 ± 60.78 (100) 100
TbTS Y430-H 0 0 0 0
TbTS T371-Q 0 0 0 0
TbTS Y191-S 0 0.6 0 12.8
TbTS W400-A 0 0 104.29 ± 8.3 (11.2) 0
trans-sialidase activity TcTSa sialidase activity TcTSb
A
B
Fig 4 Site-directed mutagenesis on TbTS (A) Relative positions of
the site-directed mutagenesis on TbTS refer to the relevant amino acids
for trans-sialidase activity on TcTS (B) Recombinant proteins were
expressed and purified as indicated in Experimental procedures.
Sialidase activity was measured using MUNen5Ac as substrate and
trans-sialidase activity was measured using sialyl-a-(2,3)-lactose and
lactose as the sialic acid donor and acceptor, respectively Activities are
expressed as nmol sialic acid per min per mg (free sialic acid for
sia-lidase activity; amount of sialic acid transferred to lactose for
trans-sialidase acitivity) The percentage of activity referred to wild-type
controls is indicated in parenthesis The values are the mean and
standard deviation of three independent determinations The
per-centage of trans-sialidase ( a ) and sialidase ( b ) activity of TcTS referred
to wild-type controls.
Trang 6trans-sialidase activities, as in TcTS The change of the
aromatic side chain (W400 A) that in the case of TrSA and
TcTS lost the capability of hydrolysing MUNen5Ac [18],
retained 11.6% of the sialidase activity when MUNen5Ac is
used as substrate (Fig 4B) The mutation at Y191S
suppressed both activities, at variance with the American
trypanosome trans-sialidase, where the substitution of Y120
practically abolishes the sialyltransferase activity while
preserving some of the sialidase activity [17,18] The
differences observed in the effect of the mutations at these
positions could arise from distinct organizations of the
catalytic sites of both trans-sialidases
The trans-sialylation activity of TbTS W400A was lost as
in TcTS W312A mutant (Fig 4 and [18]), thus indicating
that the transfer, but not the hydrolysis reaction requires a
precise orientation of the bound substrate in both enzymes
The exposed tryptophan residue in TcTS and TrSA
determined the high specificity of these enzymes towards
sialyl-a-(2,3) substrates [18], which could be explained by
unfavourable interactions of this aromatic side-chain with
sialyl-a-(2,6)-linked oligosaccharides To test if this is also
the case of TbTS, the mutant protein W400A was obtained
and assayed for activity using sialyl-a-(2,3)-lactose (3¢SL)
and sialyl-a-(2,6)-lactose (6¢SL) The mutated enzyme was
now capable of hydrolysing the a-(2,6) regioisomer, losing
the strict specificity of the wild-type enzyme for the
sialyl-a-(2,3) substrate (Fig 5)
The active sites of theT brucei
andT cruzi trans-sialidases are highly conserved
As expected from their similar function and common
evolutionary origin, critical active site residues are largely
conserved in all trypanosomal sialidases and
trans-siali-dases The 3D structure of the T rangeli sialidase bound to
2,3-didehydro-2-deoxy-N-acetylneuraminic acid
(Neu2-en5Ac, a sialidase inhibitor) [17] showed 33 amino acids
that are positioned close to the inhibitor They have at least
one atom at less than 7 A˚ from Neu2en5Ac Among these
positions, 26 amino acids (79%) are conserved between
TcTS and TbTS, 24 (73%) are conserved between TbTS
and TrSA, and 22 (67%) are conserved between TcTS and
TrSA These relative similarities differ significantly from
those found when comparing the entire catalytic domains (Fig 4), thus revealing a functional constraint on the evolution of trans-sialidases
All amino-acid residues that have been found to be important for the function in other viral and bacterial sialidases, are also conserved in the three trypanosomal enzymes (shown in b lue in Fig 6): the arginine triad (R36, R246 and R315, TrSA numbering) that binds the carboxy-late group of sialic acid; the aspartic acid residue (D60) that could serve as the proton donor in the reaction; and two residues (E231, Y343) that probably serve to stabilize the transition state intermediate Other amino-acid residues conserved in the active site of the three trypanosomal enzymes (but not necessarily in other sialidases) include R54 and D97, whose side chains make hydrogen bonding interactions with the bound inhibitor; W121, L(I)177 and Q196, all of which are part of the pocket that binds the N-acetyl group of sialic acid; D248 and E358, whose carboxylate groups make hydrogen bonds with two arginine side-chains of the triad; and W313 and Y365, are both favourably positioned to interact with the substrate
Of particular interest are seven positions that are invariant in the two trans-sialidases (T brucei and T cruzi), but differ in TrSA (shown in red in Fig 6), suggesting that they could be important for transglycosylation activity Two
of these have been previously shown to be critical for trans-sialidase activity, namely TrSA S120 and Q284, substituted, respectively, by tyrosine and proline residues in the two trans-sialidases [17,18,28] The presence of a tyrosine residue
at position 120 was shown to be critical for TcTS activity [17], probably because this aromatic side-chain residue is involved in substrate binding Also, the conservation of a sequence PGS at positions 284–286 of both trans-sialidases (substituted by the sequence QDC in TrSA, see Fig 6) confirm previous findings of Smith & Eichinger [28], who studied the role of these residues using exchange
mutagen-Fig 5 Activity of 3¢SL and 6¢SL hydrolysis of the amino-acid
substi-tution W400-A on TbTS Sialidase activity of TbTS W400A mutant
protein was measured using a-(2,3)-lactose (3¢SL) and
sialyl-a-(2,6)-lactose (6¢SL) as sialic acid donor substrates as described in
Experimental procedures.
Fig 6 Amino-acid positions close to the inhibitor Neu2en5Ac (shown in yellow) in the crystal structure of TrSA-Neu2en5Ac complex [17] Amino-acid side-chains shown in blue are strictly conserved in microbial sialidases, those shown in green are invariant in three trypanosomal enzymes (TrSA, TcTS and TbTS), and those shown in red are conserved in the two trypanosomal trans-sialidases, but differ in TrSA, and could be important for transglycosylation (see text).
Trang 7esis between TrSA and TcTS Along similar lines, Paris
et al [18] demonstrated that the substitution Q284-P in
TrSA increased significantly the hydrolytic activity of the
enzyme The three other positions in the neighbourhood of
the active site that differ between trypanosomal sialidase
and trans-sialidase are M96, F114 and V180 in TrSA,
substituted by valine, tyrosine and alanine residues in the
trans-sialidases, respectively (Fig 6) Although it is difficult
to assess the functional role of these substitutions in the
absence of a crystal structure for trans-sialidase, they could
contribute to modulation of specific protein–sialic acid
interactions, which are important for the transfer reaction to
occur
Genomic organization of TbTS genes
Southern blot analysis of total DNA from T brucei brucei
strain probed with the catalytic region of the genes showed
that TbTS genes are present in a small copy number (Fig 7),
a situation that is different from American trypanosomes
where the trans-sialidase family genes comprises at least 140
members Regarding the results obtained with enzymes that
cut at least once on each gene unit (BssHII, EcoRV and
HindIII, Fig 7A, panel I), a minimum of two
trans-sialidase-related genes can be estimated from the Southern
blot analysis It is likely that the TbTS genes are organized in
tandem, as previous evidence from cloning and sequencing
(see Fig 1) suggested that several copies may exist
Database using the fragment corresponding to the putative
catalytic domain of TbTS identified a BAC clone with a
TbTS We decided then to analyse the presence of
TS-related genes on the genome of T brucei, b ecause in
American trypanosomes these genes are abundantly
repre-sented in the parasite genome [5] We designed primers
based on the sequence of the BAC clone and performed a
PCR on genomic DNA These PCR resulted in a gene of
2109 bp that was called TbTS-like The deduced primary
sequence showed a partial conservation of the typical
sialidase motifs (FRIP and Asp box), and the absence of the
residues shown to be important for activity in the
three-dimensional structure of bacterial and protozoan sialidases
and trans-sialidases (data not shown) Southern blot
analysis with a probe corresponding to the central part of
this gene (Fig 7B) demonstrated that it is present in
one copy in T brucei (Fig 7A, panel II) We analysed
TbTS-like gene with theIPSORTprogram to subcloning and
tested its product for enzymatic activity As expected, the
new construct coded for a protein of 703 amino acids
that displayed no sialidase/trans-sialidase activity when
expressed in bacteria (Fig 7B)
D I S C U S S I O N
We are describing for the first time the gene coding for an
active trans-sialidase of the African trypanosome
Trypan-osoma brucei brucei Both sialidase and trans-sialidase
activities are mediated by the same protein, encoded by
the gene identified here The trans-sialidase in African
trypanosomes is expressed in the procyclic form, the stage of
the parasite that replicates in the tsetse fly midgut Procyclic
forms are characterized by the synthesis of a surface coat
composed of procyclins (otherwise known as procyclic acid repetitive protein) Each cell is covered by approximately six million procyclin molecules [29] that are attached to the surface membrane by GPI anchors [4] It has been shown that isolated de-sialylated procyclin can be sialylated by culture-purified trans-sialidase [30] The unusual GPI anchor of procyclin was known to contain five sialic acid molecules on its structure, but it might be sialylated in regions other than the GPI anchor, because the number of sialic acid residues is about 10 per procyclin molecule [31] The function of procyclins is unknown, although they contribute to the establishment of strong infections in the fly vector Parasites that have no surface procyclin because of a defect in GPI synthesis are less efficient at establishing infection in flies [32] Impairment of this process offers a possibility for controlling vector parasitemia (see below) Extensive work has been carried out on the molecu-larbiology, biochemistry and structure of the surface
9.4 23.1
6.6
4.4
kpb
A
2.3
2.0
SxDxGxTW
TbTS
LTIxNAMLYNR
YRSP
683 1
TbTS like
B
30% similarity
TbTs probe
TbTs like probe
Fig 7 Southern blot analysis of TbTS and TbTS-like (A) Genomic DNA of T brucei digested with the indicated restriction enzymes, hybridized with a TbTS probe (I) and TbTS-like probe (II) The filter was washed at 65 C in 0.1 · NaCl/Cit, 0.1% SDS As controls, maize DNA digested with EcoR1 and T cruzi DNA digested with PstI were used (B) Schematic representation of primary sequence of TbTS and TbTS-like Catalytic (open box) and lectin-like domains (shaded box) are shown The differences in FRIP, Asp boxes and trans-sialidase superfamily motifs are also indicated Dark bars indicate the position
of the region used as probe for Southern blot analysis.
Trang 8trans-sialidase of American trypanosome T cruzi (reviewed
in [5]), the agent of Chagas’ disease Both American and
African trans-sialidases are developmentally regulated
sur-face glycoproteins [24,34] They share a number of features
that are unusual for the rest of microbial sialidases, such as a
neutral optimum pH (6.9 for T brucei, 7.2 for T cruzi), the
independence of divalent cations, a relative resistance
towards the natural sialidase inhibitor Neu2en5Ac and the
same substrate specificity [24,33] In spite of not being
closely related in their overall primary structure, TbTS
conserves most of the amino acids relevant for the catalytic
site of American trans-sialidase The identity increases up to
45% in the region corresponding to the catalytic domain,
but TbTS contains an extra region of 100 amino acids
towards its N-terminal end In its C-terminal region, the
identity falls to 30% relative to the lectin-like domain of
American trans-sialidase The trans-sialidase gene products
of T cruzi and T brucei have a significant degree of
structural and biochemical similarity to the sialidases found
in bacteria and viruses (Fig 8) The comparison of inferred
gene trees with species trees made by alignment of the
nucleotide and predicted amino-acid sequences of sialidases
and trans-sialidase suggested that the genes encoding the
T cruzi trans-sialidase of mammalian forms might be
derived from genes expressed in the insect forms of the
genus Trypanosoma [35] It was recently demonstrated by
analysis of DNA sequences from 62 different species of this
genus that there is evidence for a common ancestor for
T cruziand T brucei around 100 million years ago [36], an
ancestor that could have carried the primitive trans-sialidase
gene
The identity in the catalytic region of the two enzymes led
us to investigate whether the same architecture of the active
site is likely to be shared by both enzymes There is growing
evidence suggesting the existence of distinct donor- and
acceptor-binding sites to account for the sialyl-transferase
activity of T cruzi enzyme, supported by recent
crystallo-graphic data of enzyme–substrate analog complexes An
inhibitor contacting residue (Y119) and a shallow
depres-sion (formed by P283, Y248 and W312) are favourably
positioned in the T cruzi enzyme to be involved in binding
the acceptor molecule P284 has been shown to be one of the
essential amino-acid residues for trans-sialylation, as a TrSA-TcTS chimerical molecule displaying only sialidase activity was able to trans-sialylate after mutation of Q284 to
a proline residue [28] The mutation of the homologous residue, P371Q, seems to induce the same effect on the structure of the active site of African trans-sialidase Our previous results on the T cruzi enzyme indicate a crucial role for Y119 in binding the acceptor carbohydrate, since the single substitution YfiS strongly affects the transfer/hydrolysis ratio towards a more efficient hydrolase, while the inverse substitution in TrSA retains a significant sialidase activity [17] The substitution of the homologous residue in TbTS, Y191, causes a dramatic effect on this enzyme, abolishing both sialidase and trans-sialidase activ-ities Many microbial sialidases, such as the enzymes from Vibrio choleraeand influenza virus can cleave a-(2,3), a-(2,6) and even a-(2,8)-linked sialic acid conjugates [14,37] Both trypanosome sialidase and trans-sialidases, as well as Salmonella typhimurium(StSA) [25] and Macrobdella decora [38] sialidases, display a high specificity for a-(2,3)-linked sialic acid conjugates We have demonstrated that a conserved tryptophan residue in American trypanosome sialidase and trans-sialidase is directly involved in the binding of sialic acid donor substrates, as the single point mutant Wfi A allowed a looser accommodation of the donor substrate, broadening their substrate specificity [18]
On the other hand, a significant decrease of hydrolytic activity against the fluorogenic substrate MUNen5Ac was shown in the case of T cruzi: hydrolysis was undetectable in the TcTS mutant In TbTS mutant, the activity falls 10-fold relative to the activity of the wild-type towards this substrate
It has been shown recently that the lectin-like domain of a trans-sialidase-related protein is involved in host cell binding activity during the T cruzi cell invasion process [27,39] The binding site to cytokeratin 18 colocalizes with the trans-sialidase/sialidase superfamily motif (VTVxNVfLYNR) [27] Because this motif is conserved in TbTS, it is possible that a cell binding activity in the lectin-like domain of TbTS could play a role in T brucei infection in tsetse flies Efforts to develop inhibitors based on the structure are currently being made for the trans-sialidase of American
trypomastigote TcTS
procyclic form TbTS
StSA
SxDxGxTW FRIP
catalytic domain lectin-like
domain
lectin-like domain (wing-2)
lectin-like domain (wing-1) VcSA
44 %
43 %
27%
23 %
31 %
33 %
Fig 8 Structural similarity between sialidases and trans-sialidases of different origins Comparison of the primary structures of the different domains (catalytic in light grey bars, lectin-like in black bars) of sialidases and trans-sialidases from trypanosomes (TrSA, T rangeli sialidase GenBank accession number U83180; TcTS, T cruzi trans-sialidase, L26499; TbTS, T brucei trans-sialidase, AF310232) and sialidases of bacterial origin (StSA, Salmonella typhimurium sialidase, M55342; VcNA, Vibrio cholerae neuraminidase, M83562) Numbers indicate the percentage of identity The developmental stage where the proteins are present, in the case of Trypanosoma species, is indicated on the left The consensus Asp-box sequence and FRIP motif are shown with vertical bars.
Trang 9trypanosomes as new alternatives for chemotherapy These
compounds are needed urgently, because the available drugs
are only effective in 50% of the acute infections and their
usefulness for parasitological cure in chronic infections is
controversial [40,41] Since the first years of the 20th
century, human and animal trypanosomiasis have been
recognized as a cause of morbidity and mortality
through-out sub-Saharan Africa and a major constraint on the use of
livestock There has been extensive international
collabor-ation and considerable expenditure on mechanisms to
control the disease and its vector [42] Given the limited
range and effectiveness of the drugs available as resistance
has emerged, modulating tsetse vector infection appears to
be an important strategy in reducing the incidence of this
disease Major advances being made by molecular
biologi-cal and genomic research will eventually lead to the
development of new approaches to control disease
trans-mission by insect vectors Although not demonstrated here,
trans-sialidase might have a relevant function for the
survival of T brucei in the tsetse vector In fact, the same
enzymatic activity has a relevant function for the survival of
T cruzi Furthermore, the gene encoding this enzyme might
have been generated millions of years ago and have been
conserved, probably as a result of its important function
Further work will demonstrate if TbTS is indeed an
essential enzyme for the parasite If so, treatment of cows
with a putative inhibitor could be used to prevent infection
in the tsetse fly and its dissemination A similar approach to
that proposed by vaccination in Plasmodium infections, the
so-called transmission blocking malaria vaccines [43]
A C K N O W L E D G E M E N T S
We would like to thank Graciela Gotz for revising the manuscript This
work was supported by grants from the World Bank/UNDP/WHO
Special Program for Research and Training in Tropical Diseases
(TDR), ECOS-SeCyT (France-Argentina), the Human Frontiers
Science Program, the Institut Pasteur and the Agencia Nacional de
Promocio´n Cientı´fica y Tecnolo´gica, Argentina The research from
ACCF was supported in part by an International Research Scholars
Grant from the Howard Hughes Medical Institute and a fellowship
from the John Simon Guggenheim Memorial Foundation.
R E F E R E N C E S
1 Borst, P & Ulbert, S (2001) Control of VSG gene expression sites.
Mol Biochem Parasitol 114, 17–27.
2 Mowatt, M.R., Wisdom, G.S & Clayton, C.E (1989) Variation of
tandem repeats in the developmentally regulated procyclic acidic
repetitive proteins of Trypanosoma brucei Mol Cell Biol 9, 1332–
1335.
3 Roditi, I., Schwarz, H., Pearson, T.W., Beecroft, R.P., Liu, M.K.,
Richardson, J.P., Buhring, H.J., Pleiss, J., Bulow, R., Williams,
R.O.& et al (1989) Procyclin gene expression and loss of the
variant surface glycoprotein during differentiation of
Trypanoso-ma brucei J Cell Biol 108, 737–746.
4 Ferguson, M.A., Murray, P., Rutherford, H & McConville, M.J.
(1993) A simple purification of procyclic acidic repetitive protein
and demonstration of a sialylated glycosyl-phosphatidylinositol
membrane anchor Biochem J 291, 51–55.
5 Frasch, A.C (2000) Functional diversity in the trans-sialidase and
mucin families in Trypanosoma cruzi Parasitol Today 16,
282–286.
6 Tomlinson, S & Raper, J (1998) Natural immunity to
trypano-somes Parasitol Today 14, 354–359.
7 Schenkman, S., Jiang, M.S., Hart, G.W & Nussenzweig, V (1991)
A novel cell surface trans-sialidase of Trypanosoma cruzi generates
a stage-specific epitope required for invasion of mammalian cells Cell 65, 1117–1125.
8 Schenkman, S & Eichinger, D (1993) Trypanosoma cruzi trans-sialidase and cell invasion Parasitol Today 9, 218–225.
9 Buschiazzo, A., Campetella, O & Frasch, A.C (1997) Trypano-soma rangeli sialidase: cloning, expression and similarity to T cruzi trans-sialidase Glycobiology 7, 1167–1173.
10 Cremona, M.L., Campetella, O., Sanchez, D.O & Frasch, A.C (1999) Enzymically inactive members of the trans-sialidase family from Trypanosoma cruzi display beta-galactose binding activity Glycobiology 9, 581–587.
11 Cremona, M.L., Sanchez, D.O., Frasch, A.C & Campetella, O (1995) A single tyrosine differentiates active and inactive Trypa-nosoma cruzi trans-sialidases Gene 160, 123–128.
12 Buscaglia, C.A., Alfonso, J., Campetella, O & Frasch, A.C (1999) Tandem amino acid repeats from Trypanosoma cruzi shed anti-gens increase the half-life of proteins in blood Blood 93, 2025– 2032.
13 Buschiazzo, A., Cremona, M.L., Campetella, O., Frasch, A.C & Sanchez, D.O (1993) Sequence of a Trypanosoma rangeli gene closely related to Trypanosoma cruzi trans-sialidase Mol Bio-chem Parasitol 62, 115–116.
14 Colman, P.M., Varghese, J.N & Laver, W.G (1983) Structure of the catalytic and antigenic sites in influenza virus neuraminidase Nature 303, 41–44.
15 Crennell, S., Garman, E., Laver, G., Vimr, E & Taylor, G (1994) Crystal structure of Vibrio cholerae neuraminidase reveals dual lectin- like domains in addition to the catalytic domain Structure
2, 535–544.
16 Gaskell, A., Crennell, S & Taylor, G (1995) The three domains of
a bacterial sialidase: a beta-propeller, an immunoglobulin module and a galactose-binding jelly-roll Structure 3, 1197–1205.
17 Buschiazzo, A., Tavares, G.A., Campetella, O., Spinelli, S., Cremona, M.L., Paris, G., Amaya, M.F., Frasch, A.C & Alzari, P.M (2000) Structural basis of sialyltransferase activity in trypa-nosomal sialidases EMBO J 19, 16–24.
18 Paris, G., Cremona, M.L., Amaya, M.F., Buschiazzo, A., Giambiagi, S., Frasch, A.C & Alzari, P.M (2001) Probing molecular function of trypanosomal sialidases: single point mutations can change substrate specificity and increase hydrolytic activity Glycobiology 11, 305–311.
19 Brun, R & Schonenberger, M (1979) Cultivation and in vitro cloning or procyclic culture forms of Trypanosoma brucei a semi-defined medium Acta Trop 36, 289–292.
20 Sambrook, J., Fritsch, E.F & Maniatis, T (1989) Molecular Cloning: a Laboratory Manual, 2nd edn Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
21 Buschiazzo, A., Frasch, A.C & Campetella, O (1996) Medium
recombinant trans-sialidase from Trypanosoma cruzi Cell Mol Biol (Noisy-le-Grand) 42, 703–710.
22 Romero, E.L., Pardo, M.F., Porro, S & Alonso, S (1997) Sialic acid measurement by a modified Aminoff method: a time-saving reduction in 2-thiobarbituric acid concentration J Biochem Biophys Methods 35, 129–134.
23 Campetella, O., Sa´nchez, D., Cazzulo, J.J & Frasch, A.C.C (1992) A superfamily of Trypanosoma cruzi surface antigens Parasitol Today 8, 378–381.
24 Engstler, M., Reuter, G & Schauer, R (1992) Purification and characterization of a novel sialidase found in procyclic culture forms of Trypanosoma brucei Mol Biochem Parasitol 54, 21–30.
25 Crennell, S.J., Garman, E.F., Laver, W.G., Vimr, E.R & Taylor, G.L (1993) Crystal structure of a bacterial sialidase (from Salmonella typhimurium LT2) shows the same fold as an influenza virus neuraminidase Proc Natl Acad Sci USA 90, 9852–9856.
Trang 1026 Cross, G.A & Takle, G.B (1993) The surface trans-sialidase
family of Trypanosoma cruzi Annu Rev Microbiol 47, 385–411.
27 Magdesian, M.H., Giordano, R., Ulrich, H., Juliano, M.A.,
Juliano, M., Schumacher, R.I., Colli, W & Alves, M.J.M (2001)
Infection by Trypanosoma cruzi Identification of a parasite ligand
and its host cell receptor J Biol Chem 276, 19382–19389.
28 Smith, L.E & Eichinger, D (1997) Directed mutagenesis of the
Trypanosoma cruzi trans-sialidase enzyme identifies two domains
involved in its sialyltransferase activity Glycobiology 7, 445–451.
29 Pays, E & Nolan, D.P (1998) Expression and function of surface
proteins in Trypanosoma brucei Mol Biochem Parasitol 91, 3–36.
30 Engstler, M., Reuter, G & Schauer, R (1993) The
devel-opmentally regulated trans-sialidase from Trypanosoma brucei
sialylates the procyclic acidic repetitive protein Mol Biochem.
Parasitol 61, 1–13.
31 Pontes de Carvalho, L.C., Tomlinson, S., Vandekerckhove, F.,
Bienen, E.J., Clarkson, A.B., Jiang, M.S., Hart, G.W &
Nussenzweig, V (1993) Characterization of a novel trans-sialidase
of Trypanosoma brucei procyclic trypomastigotes and
identifica-tion of procyclin as the main sialic acid acceptor J Exp Med 177,
465–474.
32 Nagamune, K., Nozaki, T., Maeda, Y., Ohishi, K., Fukuma, T.,
Hara, T., Schwarz, R.T., Sutterlin, C., Brun, R., Riezman, H &
Kinoshita, T (2000) Critical roles of glycosylphosphatidylinositol
for Trypanosoma brucei Proc Natl Acad Sci USA 97, 10336–
10341.
33 Ferrero-Garcia, M.A., Trombetta, S.E., Sanchez, D.O., Reglero,
A., Frasch, A.C & Parodi, A.J (1993) The action of Trypanosoma
cruzi trans-sialidase on glycolipids and glycoproteins Eur J.
Biochem 213, 765–771.
34 Affranchino, J.L., Pollevick, G.D & Frasch, A.C (1991) The expression of the major shed Trypanosoma cruzi antigen results from the developmentally-regulated transcription of a small gene family FEBS Lett 280, 316–320.
35 Briones, M.R., Egima, C.M., Eichinger, D & Schenkman, S (1995) Trans.-sialidase genes expressed in mammalian forms of Trypanosoma cruzi evolved from ancestor genes expressed in insect forms of the parasite J Mol Evol 41, 120–131.
36 Gibson, W (2001) Sex and evolution in trypanosomes Int J Parasitol 31, 643–647.
37 Taylor, G., Vimr, E., Garman, E & Laver, G (1992) Purification, crystallization and preliminary crystallographic study of neur-aminidase from Vibrio cholerae and Salmonella typhimurium LT2.
J Mol Biol 226, 1287–1290.
38 Luo, Y., Li, S.C., Chou, M.Y., Li, Y.T & Luo, M (1998) The crystal structure of an intramolecular trans-sialidase with a NeuAc alpha2 fi 3Gal specificity Structure 6, 521–530.
39 Villalta, F., Smith, C.M., Ruiz-Ruano, A & Lima, M.F (2001) A ligand that Trypanosoma cruzi uses to bind to mammalian cells to initiate infection FEBS Lett 505, 383–388.
40 Keiser, J., Stich, A & Burri, C (2001) New drugs for the treatment
of human African trypanosomiasis: research and development Trends Parasitol 17, 42–49.
41 Geerts, S., Holmes, P.H., Eisler, M.C & Diall, O (2001) African bovine trypanosomiasis: the problem of drug resistance Trends Parasitol 17, 25–28.
42 Allsopp, R (2001) Options for vector control against trypano-somiasis in Africa Trends Parasitol 17, 15–19.
43 Carter, R (2001) Transmission blocking malaria vaccines Vaccine
19, 2309–2314.